Improvement of asthma management in actual practice consistent with prevalence of anti-inflammatory agents: Based on questionnaire surveys in Niigata Prefecture, Japan from 1998 to 2002

Allergology International

Volumn 54, Issue 4, 2005, Pages 555-563

  Hasegawa, Takashi ^a,c   Suzuki, Eiichi ^b,c   Terada, Masaki ^a   Koya, Toshiyuki ^a   Toyabe, Shinichi ^b   Akazawa, Kohei ^b   Yoshizawa, Hirohisa ^a   Arakawa, Masaaki ^a,c   Gejyo, Fumitake ^a,c  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c Niigata Asthma Treatment Study Group   (Japan)

Author keywords

Asthma death; Bronchial asthma; Inhaled corticosteroid; Leukotriene receptor antagonist; Questionnaire

Indexed keywords

CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PREDNISOLONE; THEOPHYLLINE;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL PRACTICE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE CONTROL; FEMALE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP DISORDER; UNCONSCIOUSNESS;

EID: 33846808875     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.54.555     Document Type: Article

References (19)

1. Makino S, Furusho K, Miyamoto T, Ohta K. Asthma Prevention and Management Guidelines. 1998, Japan (JGL): English version. Int. Arch. Allergy Immunol. 2000;121:1-78.
2. Miyamoto T, Oshima S, Ishizaki T, Sato SH. Allergenic identity between the common floor mite (Dermatophagoides farinae Hughes, 1961) and house dust as a causative antigen in bronchial asthma. J. Allergy 1968;42:14-28.
3. Frederick JM, Warner JO, Jessop WJ, Enander I, Warner JA. Effect of a bed covering system in children with asthma and house dust mite hypersensitivity. Eur. Respir. J. 1997;10:361-366.
4. Mattoli S, Mattoso VL, Soloperto M, Allegra L, Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J. Allergy Clin. Immunol. 1991;87:794-802.
5. Bentley AM, Menz G, Storz C et al. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Am. Rev. Respir. Dis. 1992;146:500-506.
6. British Thoracic Society and others. Guidelines for the management of asthma: a summary. 1993;306:776-782.
7. National Institution of Health. National Asthma Education and Prevention Program. "Guidelines for the Diagnosis and Management of Asthma-Update on Selected Topics 2002". Bethesda:National Institute of Health, 2002.
8. Olivieri D, Chetta A, Donno ML et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma; a placebo controlled study. Am. J. Respir. Crit. Care Med. 1997;155:1864-1871.
9. Sudre P, Jacquemet S, Uldry C, Perneger TV. Obgectives, methods and content of patient education programes for adults with asthma. Thorax 1999;54:681-687.
10. Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N. Engl. J. Med. 1997;337:1412-1418.
11. Ukena D, Harnest U, Sakalauskas R et al. Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. Eur. Respir. J. 1997;10:2754-2760.
12. Van Ganse E, Laforest L, Pietri G et al. Persistent asthma: disease control, resource utilisation and direct costs. Eur. Respir. J. 2002;20:260-267.
13. Burgess C, Pearce N, Thiruchelvam R et al. Prescribed drug therapy and near-fatal asthma attacks. Eur. Respir. J. 1994;7:498-503.
14. Nakazawa T. Current asthma death situation in Japan. International Review of Asthma 2003;5:42-46.
15. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997;277:887-891.
16. Suissa S, Ernst P, Benayoun S et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N. Engl. J. Med. 2000;343:332-336.
17. Stewart AL, Hays RD, Ware JE Jr. The MOS short-term general health survey-reliability and validity in a patient population. Med. Care 1988;26:724-735.
18. McFadden ER, Casale TB, Edwards TB et al. Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma. J. Allergy Clin. Immunol. 1999;104:46-52.
19. Noonan MJ, Chervinsky P, Brandon M et al. Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group. Eur. Respir. J. 1998;11:1232-1239.